Disclosure

2

Review clinical trials related to Disclosure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AI-Driven Consent Simplification Study

The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.

Participants needed: 230
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of California, Los AngelesUpdated: May 8, 2026Locations: 1
Eligibility criteria

Age 60 years and above [+9]

Group 1: None [+2]

Status: Recruiting

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Oslo University HospitalUpdated: May 2, 2024Locations: 2
Eligibility criteria

Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to Inter... [+4]

Intellectual disability [+1]